COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients.

Soizic LeguyMathilde LefortLucile LescotAudrey MichaudSandra VukusicEmmanuelle Le PageGilles EdanAnne KerbratChristine Lebrun-FrenayJérôme De SèzeDavid-Axel LaplaudSandrine WiertlewskiEmmanuelle LerayLaure Michel

Published in: Journal of neurology (2022)

This study provides class III evidence that systematic high-dose corticosteroids are not associated with a reduced inflammatory activity during the post-partum period in multiple sclerosis patients.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
mass spectrometry
rheumatoid arthritis
ms ms
patient reported outcomes
systemic lupus erythematosus
stem cell transplantation